09:38 AM EDT, 04/29/2025 (MT Newswires) -- LifeMD ( LFMD ) said Tuesday that it plans to offer "broad, affordable, and streamlined" access to Novo Nordisk's ( NVO ) weight-loss drug Wegovy.

The company said all doses of Wegovy are available in a pen device to eligible LifeMD ( LFMD ) patients who are uninsured or do not have weight-loss medication coverage through their insurance provider.

Shares of LifeMD ( LFMD ) surged 22% in early trading Tuesday.

Price: 7.47, Change: +1.37, Percent Change: +22.46